The Practical Paraplegic

“… But people in pain may find they are robbed of words because of other people’s attitudes. “When you have a chronic illness, you tend to stop saying things because you feel the people around you don’t want to hear it anymore,” Deatherage said.
A network of people going through the same thing can help share [...]

[Read more →]

Stem-cell technology has primarily been the province of small biotechnology companies, such as Geron Corp. of Menlo Park, California and closely held Novocell Inc. of San Diego. Now scientists from Pfizer, working in labs in Cambridge, Massachusetts, and Cambridge, England, will research new treatments to spur stem cells already in people’s bodies to become active [...]

[Read more →]

SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard), today announced that it has received Orphan Drug designation from the European Commission for AX200 in the treatment of Spinal Cord Injury (SCI). This follows the positive recommendation that SYGNIS received from the EMEA in September.
Orphan Drug designation can be granted for a product that is [...]

[Read more →]